Biomarkers in the prognostic evaluation of ischemic stroke: Is there benefit in the measurements of TREM-1 and TREM-2 in the acute phase?

Title
Biomarkers in the prognostic evaluation of ischemic stroke: Is there benefit in the measurements of TREM-1 and TREM-2 in the acute phase?
Authors
Keywords
Cerebral ischemic stroke, Blood biomarkers, Outcome, Triggering receptor expressed on myeloid cells type 1 (TREM1), Triggering receptor expressed on myeloid cells type 2 (TREM2)
Journal
CLINICAL BIOCHEMISTRY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-07-30
DOI
10.1016/j.clinbiochem.2021.07.016

Ask authors/readers for more resources

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now